268 related articles for article (PubMed ID: 17061911)
1. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
Ronaldson KJ; O'Shea JM; Boyd IW
Drug Saf; 2006; 29(11):1061-7. PubMed ID: 17061911
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
Golomb B; Evans M
Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465
[No Abstract] [Full Text] [Related]
3. Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors.
Molden E; Skovlund E; Braathen P
Drug Saf; 2008; 31(7):587-96. PubMed ID: 18558792
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis with concurrent atorvastatin and diltiazem.
Lewin JJ; Nappi JM; Taylor MH
Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603
[TBL] [Abstract][Full Text] [Related]
5. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
McAdams M; Staffa J; Dal Pan G
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
[TBL] [Abstract][Full Text] [Related]
6. [Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
Gabignon C; Zeller V; Le Guyader N; Desplaces N; Lidove O; Ziza JM
Rev Med Interne; 2013 Jan; 34(1):39-41. PubMed ID: 23102978
[TBL] [Abstract][Full Text] [Related]
7. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
Alsheikh-Ali AA; Karas RH
Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402
[TBL] [Abstract][Full Text] [Related]
8. Judicious evaluation of adverse drug reactions: inaccurate assessment of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced muscle injury.
Dietz BL; Oberg KC
Pharmacotherapy; 1999 Feb; 19(2):232-5. PubMed ID: 10030775
[TBL] [Abstract][Full Text] [Related]
9. Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.
Cannon CS
JAAPA; 2012 Aug; 25(8):30, 32-3. PubMed ID: 22928274
[No Abstract] [Full Text] [Related]
10. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
Maltz HC; Balog DL; Cheigh JS
Ann Pharmacother; 1999 Nov; 33(11):1176-9. PubMed ID: 10573315
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment associated with atorvastatin and simvastatin.
King DS; Wilburn AJ; Wofford MR; Harrell TK; Lindley BJ; Jones DW
Pharmacotherapy; 2003 Dec; 23(12):1663-7. PubMed ID: 14695047
[TBL] [Abstract][Full Text] [Related]
13. [Interaction risk with statin switch].
Molden E; Westergren T
Tidsskr Nor Laegeforen; 2007 Feb; 127(4):428-31. PubMed ID: 17304269
[TBL] [Abstract][Full Text] [Related]
14. The statins: drug interactions of significance to the dental practitioner.
Stevenson H; Longman LP; Randall C; Field EA
Dent Update; 2006; 33(1):14-6, 18, 20. PubMed ID: 16512094
[TBL] [Abstract][Full Text] [Related]
15. Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones.
Alsheikh-Ali AA; Karas RH
Am J Cardiol; 2004 Jun; 93(11):1417-8, A9. PubMed ID: 15165929
[TBL] [Abstract][Full Text] [Related]
16. [Rhabdomyolysis associated to combined ezetimibe-statin treatment].
Piedra León M; García Unzueta MT; Otero Martínez M; Amado Señaris JA
Rev Clin Esp; 2007 Sep; 207(8):425-6. PubMed ID: 17688879
[No Abstract] [Full Text] [Related]
17. Spontaneous reports cannot serve as a basis for comparison of two drugs.
Jones JK
Am J Cardiol; 2003 Nov; 92(9):1141-2. PubMed ID: 14583380
[No Abstract] [Full Text] [Related]
18. Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.
Rätz Bravo AE; Tchambaz L; Krähenbühl-Melcher A; Hess L; Schlienger RG; Krähenbühl S
Drug Saf; 2005; 28(3):263-75. PubMed ID: 15733030
[TBL] [Abstract][Full Text] [Related]
19. Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins.
Montastruc JL
Br J Clin Pharmacol; 2023 Aug; 89(8):2636-2638. PubMed ID: 37186323
[TBL] [Abstract][Full Text] [Related]
20. High-dose statins and the IDEAL study.
Ravnskov U; Rosch PJ; Sutter MC
JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
